Founded in 2022 and headquartered in Seoul, South Korea, LOTTE Biologics operates integrated biologics facilities in the United States and South Korea. Through a unified Dual Hub Service model, LOTTE Biologics enhances supply security, supports manufacturing scalability, and maintains consistent quality standards across regions.

LOTTE Biologics provides modular, phase-appropriate manufacturing solutions spanning preclinical through commercial stages, with proven capability in producing mammalian-cell-based biologics, including monoclonal antibodies, fusion proteins, and multispecific modalities. 

At the Syracuse Bio Campus in New York, LOTTE Biologics delivers high-quality GMP drug substance manufacturing supported by more than 62 global regulatory approvals. The site offers 40,000 L of total capacity across eight 5,000 L stainless steel bioreactors and includes analytical and warehouse infrastructure. In addition, the company has expanded into Antibody-Drug Conjugates (ADCs) through strategic investment in onsite conjugation suites, enabling a streamlined, end-to-end pathway from biologic drug substance production to ADC manufacturing within a single campus.

In South Korea, LOTTE Biologics is constructing three advanced bio plants at the Songdo Bio Campus. With the first facility already underway and scheduled for operation in 2027, each plant will include eight 15,000 L stainless steel bioreactors for commercial production, supported by multiple 3,000 L bioreactors for clinical-scale needs. Collectively, these plants will provide a manufacturing volume exceeding 360,000L in bioreactor capacity.

Guided by the vision “Possibilities Beyond Limits,” LOTTE Biologics is committed to serving as a long-term, trusted partner, supporting efficient scale-up, dependable manufacturing execution, and the continuous advancement of clients’ therapeutic programs.

LOTTE Biologics

This department conducts research and development in various scientific areas to advance knowledge and innovation.

Scientific Research

This department is responsible for ensuring the quality and compliance of products and processes through rigorous validation and assessment.

Quality Assurance

This department manages employee relations, recruitment, training, and organizational development.

Human Resources

This department focuses on identifying growth opportunities, building client relationships, and driving sales initiatives.

Business Development

This department focuses on the design, implementation, and optimization of manufacturing processes to enhance production efficiency and quality.

Manufacturing Engineering

This department oversees the operations, quality control, and analytical processes involved in manufacturing biologics and related products.

LOTTE Biologics

Org chart

Teams

Scientific Research

Quality Assurance

Human Resources

Business Development

Manufacturing Engineering

Manufacturing and Quality

Offices

LOTTE Biologics

Org chart

Teams

Scientific Research

Quality Assurance

Human Resources

Business Development

Manufacturing Engineering

Manufacturing and Quality

Offices

Related companies